MarginsXMarginsX
Home › Markets › Health Care › BWAY

BrainsWay Ltd. (BWAY)

BWAY trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$9.39
-7.12% on the day
Market cap
$376.8M
Small cap
Revenue · 2025
$52.2M
+27.3% on 2024
Net income · 2025
$7.6M
14.5% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1505065/000117184326002568/0001171843-26-002568-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBWAY on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO year2019
SEC CIK0001505065
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inIsrael

Financials · 2025

LineValue
Revenue$52.2M
Net income$7.6M
Operating income$4.3M
Net margin14.5%
Operating margin8.3%
Revenue growth+27.3%
Cash$67.7M
Total assets$113.2M
P/E (computed)49.7×
P/S (computed)7.2×

Warning signs

Cash runway
Cash-flow positive
$67.7M cash at December 31, 2025
Share count, 1 year
-48.0%
2024-12-31 to 2025-12-31 · -40.8% over 3 years
Going-concern doubt
No
20-F filed April 20, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-04-20
Cash and burn$67.7M cash; operating cash flow $4.4M a quarter.Report 2025-12-31
Shares outstanding39,165,806 (2025-12-31); 37,626,427 a year earlier; 33,053,323 three years earlier. 1y figure adjusted for split (2-for-1 overall); 3y figure adjusted for split (2-for-1 overall); the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKost Forer Gabbay & Kasierer, Tel Aviv, IsraelPCAOB Form AP 2026-05-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$52.2M$7.6M$17.5M$67.7MNo debt tags$52.2M20-F 2026-04-20
FY 2024
2024-12-31
$41.0M$2.9M$10.3M$69.3MNo debt tags$41.0M20-F 2025-04-22
FY 2023
2023-12-31
$31.8M-$4.2M$1.3M$10.5MNo debt tags$31.8M20-F 2025-04-22
FY 2022
2022-12-31
$27.2M-$13.3M-$9.8M$47.6MNo debt tags$27.2M20-F 2025-04-22
FY 2021
2021-12-31
$29.7M-$6.5M$884K$16.9MNo debt tags$29.7M20-F 2024-03-28
FY 2020
2020-12-31
$22.1M-$5.4M-$1.4M$17.0MNo debt tags$22.1M20-F 2023-03-27
FY 2019
2019-12-31
$23.1M-$10.3M-$7.2M$21.7MNo debt tags$23.1M20-F 2022-04-12
FY 2018
2018-12-31
$16.4M-$6.5M-$3.8M$9.0M$2.8M$16.4M20-F 2021-04-19

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B3
424B32025-05-01
Latest annual report
FORM 20-F
20-F2026-04-20
Latest quarterly / interim
FORM 6-K
6-K2026-11-10

Source: SEC EDGAR submissions feed, 283 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-9.3%
1 month-15.2%
3 months-38.6%
Year to date+6.3%
1 year+26.3%
From 52-week high-41.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
CERSCerus Corporation$1.86-6.30%$375.6M
EMBCEmbecta Corp.$6.25-3.25%$354.1M
SIShoulder Innovations Inc.$20.45-1.16%$427.9M
MOBIMobia Medical Inc.$13.15-0.15%$438.3M
MDXGMiMedx Group Inc$3.18-0.93%$464.0M
CARLCarlsmed Inc.$17.35+1.34%$475.5M
RCELAvita Medical Inc.$15.22-2.62%$478.2M
INFUInfuSystems Holdings Inc.$14.79+0.48%$296.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier